March 12, 2014 | Israeli pharmaceutical company Can-Fite Biopharma has raised $5 million in private placement from US investors. The company says it will use the proceeds for further clinical trials of its psoriasis, glaucoma, and liver cancer treatments.
Related posts
Red Algae Can Treat Wounds And Infections
January 26, 2023
Freight Planner Lists on Nasdaq And Raises $80M
January 26, 2023
$6M Investment For “Lettuce Milk” Startup
January 25, 2023
Israel Has World’s Best Value Internet
January 25, 2023
Facebook comments